Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS

Files

Janssen, J.

Lowenberg, B.

Manz, M.

Bargetzi, Mario

Biemond, Bart J.

Borne, Peter von dem

Velden, W.J.F.M. Walter

Norden, Yvette van

Ossenkoppele, G.J.